OniX OnPoint Issue #14: Advancements in cancer immunotherapy and oncology
Martin A. Dueñas
OniX - Connecting Ideas to Opportunities | Biotech Innovation Accelerator | Academic Research to Market | Strategic Partnerships | Funding Strategist
🚀 Just Released: OniX OnPoint Issue #14
Our latest OniX OnPoint newsletter showcases cutting-edge advancements in cancer immunotherapy and oncology, highlighting innovative research in immune checkpoint regulation from institutions like LSU Health Science Center, University College London, and Harvard Medical School. This issue also reports on over $460 million in funding milestones for biotech leaders like Evommune and Axonis Therapeutics, along with significant technology transfer developments enhancing T cell therapies and biomarker-driven treatments. Discover how these breakthroughs are driving the future of oncology solutions!
Our comprehensive analysis covers everything from technology transfer and sponsored projects to startup innovations and the latest research breakthroughs.
Want More? Join Our Community!